TITLE

Towards a vaccine against H contortus

PUB. DATE
January 2010
SOURCE
Veterinary Record: Journal of the British Veterinary Association;1/2/2010, Vol. 166 Issue 1, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the study conducted by a group of scientists regarding the possibility to immunise sheep against the parasitic roundworm Haemonchus contortus in Edinburgh, Scotland. It states that the researchers are hoping to produce the vaccine commercially by extracting it from adult worms. It adds that the process works by using a machine to harvest clean worms from the stomachs of infected sheep to make a large volume of vaccine.
ACCESSION #
47572257

 

Related Articles

  • Half of U.S. Adults Refuse Flu Shot: Survey.  // Clinical Infectious Diseases;1/15/2009, Vol. 48 Issue 2, pii 

    The article reports on the findings of a survey conducted by Consumer Reports Health regarding the compliance of U.S. adults on flu vaccination. The survey revealed that nearly half of adults plan on skipping their flu shot in 2009 and about 48% of them said they would not get vaccinated....

  • Persistent efficacy of doramectin against Haemonchus contortus in goats. Molina, J. M.; Ruiz, A.; Fuentes, P.; Gonzáles, J. F.; Martín, S.; Hernández, Y. I. // Veterinary Record: Journal of the British Veterinary Association;4/2/2005, Vol. 156 Issue 14, p448 

    Describes a study of the persistence of the efficacy of an injectable formulation of doramectin against Haemonchus contortus in goats experimentally infected with a low burden of the parasite in Canary Islands. Isolation of the strain of H. contortus on Gran Canaria from a goat slaughtered at...

  • Plunging MMR uptake leaves UK close to endemic measles. Clarke-Jones, Joanna // Pulse;11/10/2003, Vol. 63 Issue 45, p4 

    Reports on the results of the research on the use of measles, mumps, and rubella (MMR) vaccination in Great Britain. Decline of the MMR vaccination; Influence of the decline on the increased measles cases; Possibility of a measles epidemic during the winter of 2003.

  • Mayo Clinic Researchers Use Human Vaccine to Cure Prostate Cancer in Mice.  // Biomedical Market Newsletter;6/30/2011, p558 

    The article reports on the move of Mayo Clinic researchers to use human vaccine to cure prostate cancer in mice in the U.S. It mentions that the novel cancer treatment approach allows the immune system to rid itself of prostate tumors without assistance from toxic chemotherapies and radiation...

  • Optimization of a DNA Vaccine Against SARS. Zakhartchouk, Alexander N.; Viswanathan, Sathiyanarayanan; Moshynskyy, Igor; Petric, Martin; Babiuk, Lorne A. // DNA & Cell Biology;Oct2007, Vol. 26 Issue 10, p721 

    Severe acute respiratory syndrome coronavirus (SARS-CoV) first appeared in Southern China in November 2002, and then quickly spread to 33 countries on five continents along international air travel routes. Although the SARS epidemic has been contained, there is a clear need for a safe and...

  • The influence of childhood BCG vaccination on tuberculin reactivity in adults with different risk factors. Yalçin, S. Songül; Güler, Çagatay; Yalçin, S Songül; Güler, Cağatay // Tropical Doctor;Jan2005, Vol. 35 Issue 1, p26 

    The article focuses on the relationship between tuberculin response and parameters involving age and the percentage of bacille calmette-guerin (BCG) vaccinations of workers in Bolu, Turkey. To determine tuberculin response and parameters of BCG vaccination of workers, researchers conducted a...

  • Learning from our successes. Dadley-Moore, Davina // Nature Reviews Immunology;Apr2006, Vol. 6 Issue 4, p1 

    Presents information on research being done by Troy Querec and colleagues on the reason for the effectiveness of yellow-fever vaccine, published in "The Journal of Experimental Medicine." Main component of yellow-fever vaccine; Description on how yellow-fever vaccine works; Details on the...

  • Vaccine Adjuvants Revisited. Grubhofer, Nikolaus A. // Open Veterinary Science Journal;2008, Vol. 2, p63 

    A huge amount of evidence has been made available on various adjuvants as immunological auxiliaries. Very few of them, however, have made it into commercial vaccines. Their defining properties and uses are discussed in the following mini-review.

  • Incidence of Haemophilus influenzae type b meningitis during 18 years of vaccine use: observational study using routine hospital data. Peltola, Heikki; Salo, Eeva; Saxén, Harri // BMJ: British Medical Journal (International Edition);1/1/2005, Vol. 330 Issue 7481, p18 

    Presents a study on the isolated failures of Haemophilus influenzae type b (Hib) conjugate vaccines in the Netherlands and Great Britain which resulted in Hib diseases, despite its spectacular success in the developed world. Details of the study, including methods and results; Explanation for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics